Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) Lincoff AM et al., NEJM 2023: 20% MACE reduction in adults with CVD and overweight/obesity
Concerning Symptoms Normal: Mild nausea, feeling full quickly, reduced appetite Concerning: Severe nausea, vomiting, severe abdominal pain, difficulty swallowing Regular Check-ins Your doctor will want to monitor: How youre responding to the medication Any side effects youre experiencing Your weight loss progress Blood sugar levels (if applicable) At Yorktown Health, we provide comprehensive monitoring and support throughout your GLP-1 journey
In the depths of winter, its hard not to wish for a pill that could simply burn off those extra calories
For individuals actively trying to conceive, discontinuation with appropriate washout periods is essential
Tirzepatide improves HRQoL compared with insulin lispro in poorly controlled basal insulin-treated adults with long-standing T2D (SURPASS-6) [abstract no
What Is IGF-1 LR3